Glenn D. Rosen, MD

Associate Professor of Medicine
Stanford University School of Medicine
Stanford, California

Glenn D. Rosen, MD, is Associate Professor of Medicine, Interim Co–Chief, and Director of the Interstitial Lung Disease Program at Stanford University School of Medicine. The ILD Center supports translational research and clinical care, and is actively involved in clinical trials in pulmonary fibrosis. Dr. Rosen received his bachelor's degree and medical degree from the University of Pennsylvania in Philadelphia. He completed his residency in Internal Medicine at Graduate Hospital in Philadelphia, and performed his fellowships in Pulmonary Medicine at the University of California, San Francisco, and Washington University in St. Louis, Missouri. Dr. Rosen is board certified in Internal Medicine with a subspecialty certification in Pulmonary Diseases.

Dr. Rosen has been awarded the Research Fellowship Grant Award and Career Investigator Award from the American Lung Association, the Stanford Institutional American Cancer Award, and the Jack Elway Memorial Fund Award for Lung Cancer Research. He is a member of various professional medical associations, including the American Thoracic Society.

Dr. Rosen has been widely published in a number of peer-reviewed journals and publications on apoptosis, pulmonary fibrosis, and lung cancer. He serves on the editorial board of Cancer Biology and Therapy.

Disclosure Statement

It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty involved in the development of this activity have disclosed any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a faculty member with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all faculty conflicts of interest prior to the release of this activity.

Glenn D. Rosen, MD, has served as a consultant for Celgene and received honoraria from Boehringer Ingelheim, GlaxoSmithKline, Pfizer, and Schering-Plough.

Disclaimer
The opinions, recommendations, and guidelines expressed herein are those of the PILOT™ Steering Committee and other contributing faculty, and not necessarily those of The France Foundation or InterMune, who assume no responsibility or liability for the material that appears herein.